• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Health status outcomes after acute myocardial infarction in patients without standard modifiable risk factors.无标准可改变危险因素的患者急性心肌梗死后的健康状况结局
Am Heart J. 2025 Mar;281:123-132. doi: 10.1016/j.ahj.2024.11.018. Epub 2024 Dec 3.
2
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.非标准可调节风险因素的 STEMI 患者的死亡率:SWEDEHEART 注册研究数据的性别细分分析。
Lancet. 2021 Mar 20;397(10279):1085-1094. doi: 10.1016/S0140-6736(21)00272-5. Epub 2021 Mar 9.
3
Association of Diabetes Mellitus With Health Status Outcomes in Young Women and Men After Acute Myocardial Infarction: Results From the VIRGO Study.糖尿病与急性心肌梗死后年轻男性和女性健康状况结局的相关性:来自 VIRGO 研究的结果。
J Am Heart Assoc. 2019 Sep 3;8(17):e010988. doi: 10.1161/JAHA.118.010988. Epub 2019 Aug 23.
4
Association of Lipoprotein (a) and Standard Modifiable Cardiovascular Risk Factors With Incident Myocardial Infarction: The Mass General Brigham Lp(a) Registry.脂蛋白(a)与标准可调节心血管风险因素与心肌梗死事件的关系:麻省总医院布里格姆脂蛋白(a)登记研究。
J Am Heart Assoc. 2024 May 21;13(10):e034493. doi: 10.1161/JAHA.123.034493. Epub 2024 May 18.
5
Mortality in Patients Hospitalized With Acute Myocardial Infarction Without Standard Modifiable Risk Factors: The ARIC Study Community Surveillance.急性心肌梗死住院患者无标准可调节风险因素的死亡率:ARIC 研究社区监测。
J Am Heart Assoc. 2023 Jul 4;12(13):e027851. doi: 10.1161/JAHA.122.027851. Epub 2023 Jun 29.
6
Number of standard modifiable risk factors and mortality in patients with first-presentation ST-segment elevation myocardial infarction: insights from China Acute Myocardial Infarction registry.首次出现 ST 段抬高心肌梗死患者的标准可修正风险因素数量与死亡率:来自中国急性心肌梗死注册登记研究的观察。
BMC Med. 2022 Jul 6;20(1):217. doi: 10.1186/s12916-022-02418-w.
7
Sex Differences in 1-Year Health Status Following Percutaneous Coronary Intervention in Patients Without Acute Myocardial Infarction: Results From the China PEACE Prospective Study.非急性心肌梗死患者经皮冠状动脉介入治疗后 1 年健康状况的性别差异:来自中国冠心病患者前瞻性研究的结果。
J Am Heart Assoc. 2020 Mar 17;9(6):e014421. doi: 10.1161/JAHA.119.014421. Epub 2020 Mar 5.
8
Association of clinical, laboratory and imaging biomarkers with the occurrence of acute myocardial infarction in patients without standard modifiable risk factors - rationale and design of the "Beyond-SMuRFs Study".无标准可调节风险因素的患者中临床、实验室和影像学生物标志物与急性心肌梗死发生的相关性研究 - "Beyond-SMuRFs 研究"的原理和设计。
BMC Cardiovasc Disord. 2023 Mar 23;23(1):149. doi: 10.1186/s12872-023-03180-4.
9
Association Between Cardiac Rehabilitation Participation and Health Status Outcomes After Acute Myocardial Infarction.急性心肌梗死后心脏康复参与度与健康状况结果之间的关联
JAMA Cardiol. 2016 Dec 1;1(9):980-988. doi: 10.1001/jamacardio.2016.3458.
10
Characteristics and outcomes of patients with no standard modifiable risk factors undergoing primary revascularization for acute myocardial infarction: Insights from the nationwide Japanese percutaneous coronary intervention registry.无标准可调节风险因素的急性心肌梗死患者行直接经皮冠状动脉介入治疗的特征和结局:来自全国性日本经皮冠状动脉介入治疗注册研究的启示。
Am Heart J. 2023 Apr;258:69-76. doi: 10.1016/j.ahj.2023.01.009. Epub 2023 Jan 13.

本文引用的文献

1
Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial.老年人慢性冠状动脉疾病的健康状况和临床结局:ISCHEMIA 试验。
J Am Coll Cardiol. 2023 May 2;81(17):1697-1709. doi: 10.1016/j.jacc.2023.02.048.
2
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR 胸痛评估与诊断指南:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2021 Nov 30;144(22):e368-e454. doi: 10.1161/CIR.0000000000001029. Epub 2021 Oct 28.
3
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.非标准可调节风险因素的 STEMI 患者的死亡率:SWEDEHEART 注册研究数据的性别细分分析。
Lancet. 2021 Mar 20;397(10279):1085-1094. doi: 10.1016/S0140-6736(21)00272-5. Epub 2021 Mar 9.
4
Interpretation of the Seattle Angina Questionnaire as an Outcome Measure in Clinical Trials and Clinical Care: A Review.西雅图心绞痛问卷解读作为临床试验和临床护理中的结局指标:综述。
JAMA Cardiol. 2021 May 1;6(5):593-599. doi: 10.1001/jamacardio.2020.7478.
5
Association of Cardiovascular Disease Risk Factor Burden With Progression of Coronary Atherosclerosis Assessed by Serial Coronary Computed Tomographic Angiography.心血管疾病风险因素负担与冠状动脉粥样硬化进展的关联:基于连续冠状动脉计算机断层血管造影评估。
JAMA Netw Open. 2020 Jul 1;3(7):e2011444. doi: 10.1001/jamanetworkopen.2020.11444.
6
ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?无标准可调节心血管风险因素的 ST 段抬高型心肌梗死(STEMI)患者——他们有多常见,其结局如何?
J Am Heart Assoc. 2019 Nov 5;8(21):e013296. doi: 10.1161/JAHA.119.013296. Epub 2019 Nov 1.
7
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2019美国心脏病学会/美国心脏协会心血管疾病一级预防指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2019 Sep 10;74(10):e177-e232. doi: 10.1016/j.jacc.2019.03.010. Epub 2019 Mar 17.
8
Development and validation of a short version of the Seattle angina questionnaire.西雅图心绞痛问卷简版的开发与验证
Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):640-7. doi: 10.1161/CIRCOUTCOMES.114.000967. Epub 2014 Sep 2.
9
Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry.急性心肌梗死患者健康状况潜在差异的转化研究(TRIUMPH):一项前瞻性多中心注册研究的设计与原理
Circ Cardiovasc Qual Outcomes. 2011 Jul;4(4):467-76. doi: 10.1161/CIRCOUTCOMES.110.960468.
10
Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial.急性冠状动脉综合征后心绞痛的经济影响:来自MERLIN-TIMI 36试验的见解。
Circ Cardiovasc Qual Outcomes. 2009 Jul;2(4):344-53. doi: 10.1161/CIRCOUTCOMES.108.829523. Epub 2009 Jun 2.

无标准可改变危险因素的患者急性心肌梗死后的健康状况结局

Health status outcomes after acute myocardial infarction in patients without standard modifiable risk factors.

作者信息

Ikemura Nobuhiro, Chan Paul S, Gosch Kensey, Nguyen Dan D, Iv Charles F Sherrod, Khan Mirza, Lu Yuan, Sawano Mitsuaki, Krumholz Harlan M, Spertus John A

机构信息

University of Missouri-Kansas City's Healthcare Institute for Innovations in Quality, Kansas City, MO; Saint Luke's Mid America Heart Institute, Kansas City, MO; Department of Cardiology, Keio University School of Medicine, Tokyo.

University of Missouri-Kansas City's Healthcare Institute for Innovations in Quality, Kansas City, MO; Saint Luke's Mid America Heart Institute, Kansas City, MO.

出版信息

Am Heart J. 2025 Mar;281:123-132. doi: 10.1016/j.ahj.2024.11.018. Epub 2024 Dec 3.

DOI:10.1016/j.ahj.2024.11.018
PMID:39638274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11810589/
Abstract

BACKGROUND

Prior studies of patients presenting with acute myocardial infarction (AMI) without Standard Modifiable Risk Factors (SMuRFs), such as diabetes, dyslipidemia, hypertension, and smoking, reported higher in-hospital but lower long-term mortality than those with SMuRFs. However, the impact of SMuRFs on health status outcomes (patients' symptoms, function, and quality of life) after a first AMI are unknown.

METHODS

Data from 2 prospective registries, PREMIER and TRIUMPH, were used to identify patients with no prior history of coronary disease hospitalized at 31 U.S. hospitals for AMI between 2003 and 2008. Serial health status over 12 months was collected using the Seattle Angina Questionnaire (SAQ) Summary Score. Changes in SAQ over 12 months were compared between patients with and without SMuRFs using hierarchical linear mixed models with sequential adjustments for baseline SAQ scores, clinical, and sociodemographic characteristics.

RESULTS

Among 4076 patients with a first AMI (mean age 58.4 ± 12.4, 34% female, 22% Black), 569 (14.0%) presented without SMuRFs. Compared with patients with SMuRFs, those without SMuRFs were more likely to be male, White, have higher income and education, fewer depressive symptoms, and higher baseline SAQ Summary Scores (83.5 ± 13.2 vs. 79.6 ± 16.5). After adjusting for baseline SAQ scores, patients without SMuRFs had larger SAQ Summary Score improvements at 12 months than those with SMuRFs (adjusted difference between groups = 2.61 points, 95% CI: 1.29-3.93), but sequential adjustment for clinical and socioeconomic characteristics attenuated this difference (1.69 points, 95% CI 0.40-1.97).

CONCLUSIONS

Among AMI patients, those without modifiable risk factors had similar health status at 12-months as compared with those having modifiable cardiovascular risk factors, which should provide reassurance to those with less targets for secondary prevention.

摘要

背景

先前针对无糖尿病、血脂异常、高血压和吸烟等标准可改变风险因素(SMuRFs)的急性心肌梗死(AMI)患者的研究报告称,这些患者的院内死亡率较高,但长期死亡率低于有SMuRFs的患者。然而,SMuRFs对首次AMI后健康状况结局(患者症状、功能和生活质量)的影响尚不清楚。

方法

利用来自PREMIER和TRIUMPH这两个前瞻性登记处的数据,识别2003年至2008年间在美国31家医院因AMI住院且无冠心病病史的患者。使用西雅图心绞痛问卷(SAQ)总结评分收集12个月内的连续健康状况数据。采用分层线性混合模型,对基线SAQ评分、临床和社会人口学特征进行序贯调整,比较有和无SMuRFs的患者12个月内SAQ的变化。

结果

在4076例首次AMI患者中(平均年龄58.4±12. / 4,34%为女性,22%为黑人),569例(14.0%)无SMuRFs。与有SMuRFs的患者相比,无SMuRFs的患者更可能为男性、白人,收入和教育水平更高,抑郁症状更少,基线SAQ总结评分更高(83.5±13.2 vs. 79.6±16.5)。在调整基线SAQ评分后,无SMuRFs的患者在12个月时SAQ总结评分的改善幅度大于有SMuRFs的患者(组间调整差异=2.61分,95%CI:1.29 - 3.93),但对临床和社会经济特征进行序贯调整后,这种差异有所减弱(1.69分,95%CI 0.40 - 1.97)。

结论

在AMI患者中,无可改变风险因素的患者在12个月时的健康状况与有可改变心血管风险因素的患者相似,这应为二级预防目标较少的患者提供安心感。